Catheter Biofilm
Catheter Biofilm - Related Videos
02:51
Catheter-Associated Urinary Tract Infection in a Mouse Model
0 Views •
2026
Source: Conover, M. S., et al., J. Establishment and Characterization of UTI and CAUTI in a Mouse Model. J. Vis. Exp. (2015)This video demonstrates the procedure for assembling and implanting a transurethral catheter in a female mouse, followed by bacterial inoculation to establish catheter-associated urinary tract infection and investigate biofilm-mediated host-pathogen interactions.
03:50
Candida albicans Biofilm Formation in an In Vivo Mouse Model
0 Views •
2025
This video demonstrates the development of an in vivo mouse model to study the biofilm formation of Candida albicans in subcutaneous tissue. The experiment involves implanting Candida-infected devices in the animal's back region for biofilm development.
09:03
Growth of Mycobacterium tuberculosis Biofilms
0 Views •
Cited by 79 •
2012
Mycobacterium tuberculosis forms drug tolerant biofilms when cultured in certain conditions. Here we describe methods for culturing M. tuberculosis biofilms and determining the frequency of drug tolerant persisters. These protocols will be useful for further studies into the mechanisms of drug tolerance in M. tuberculosis.
11:39
Peripheral Intravenous Catheter Insertion
0 Views •
2023
Source: Madeline Lassche, MSNEd, RN and Katie Baraki, MSN, RN, College of Nursing, University of Utah, UT The purpose of peripheral intravenous catheter (PIV) insertion is to infuse medications, perform intravenous (IV) fluid therapy, or inject radioactive tracers for special examination procedures. Placing a PIV is an invasive procedure and requires the use of an aseptic, no-touch technique. Common IV venipuncture sites are the arms and hands in adults and the feet in children. According to...
10:17
Methodologies for Studying B. subtilis Biofilms as a Model for Characterizing Small Molecule Biofilm Inhibitors
0 Views •
Cited by 28 •
2016
This study presents the development of reproducible methodologies to study biofilm inhibitors and their effects on Bacillus subtilis multicellularity.
FAQs
Formation begins when microorganisms adhere to the catheter surface. This initial attachment creates a platform for continued community development and extracellular polymeric matrix production. The matrix anchors cells to the device and changes the infection from a transient microbial presence into a persistent, surface-associated problem, making catheter-associated disease an important focus of infection research.
The extracellular polymeric matrix provides structural support while limiting antimicrobial penetration. Because treatment may not reach all organisms effectively within the matrix, the microbial community can persist despite antimicrobial therapy. This protective environment also contributes to treatment failure, linking the physical organization of the biofilm directly to clinical challenges in managing device-associated infection.
The matrix helps protect organisms from immune clearance, allowing microbial communities to remain associated with the catheter. Their persistence can sustain local inflammation and contribute to infection involving the urinary tract or bloodstream. From an immunology perspective, the key issue is that host defenses encounter organisms protected within a device-associated structure rather than freely exposed cells.
Consequences vary with the catheter location and the persistence of the microbial community. Urinary devices may be associated with urinary tract infection and catheter blockage, while vascular devices can contribute to bloodstream infection. Across device types, biofilm formation may also promote inflammation and treatment failure, making catheter-associated disease both an infectious and device-management concern.
Understanding the sequence from microbial adhesion to matrix formation identifies stages that catheter design and infection-prevention strategies may need to address. The overview supports these approaches as important applications of biofilm research, particularly for reducing persistent device-associated infection. Such work connects the physical properties of an indwelling device with the microbial and immune processes occurring at its surface.
It is especially relevant when infection persists, antimicrobial treatment fails, or a catheter becomes blocked. The matrix can limit antimicrobial penetration, while protection from immune clearance allows organisms to remain associated with the device. Consequently, biofilm knowledge helps frame antimicrobial therapy and broader disease management as problems requiring attention to both microorganisms and the catheter surface.